Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Aptargroup Q3 2026 Results: Net Income $32.6M, Down 74.5% YoY

AptarGroup reported net sales of $1.02 billion for the quarter ended September 30, 2026, a 6% increase over the prior year, though net income fell significantly to $32.6 million due to a $58 million loss on the deconsolidation of its Russian operations. For the nine-month period, net income was $192.8 million compared to $318.4 million in 2025, reflecting the impact of the Russia exit and higher interest expenses.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue1,019.1961.1
Profit before tax60.3154.1
Net income32.6127.9
EPS (diluted, $ a share)$0.51$1.92

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Net income, year on year-74.5%
Revenue, year on year+6.0%
Operating margin13.2%
Source

10-Q filed with the SEC, NYSE: ATR. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Aptargroup, Inc.: key numbers

Share price
$143.17Close, Nov 16
Market cap
$9.08B
Shares outstanding
63.39MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Plastics Products, NECSIC 3089

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Aptargroup, Inc.

All →
4:23 PM ET Form 4
Insider Selling

Aptargroup Segment President Marc Prieur Sells $284K of Stock

Marc Prieur, Segment President, sold 2,000 shares of Aptargroup, Inc. at $141.99 a share, worth $284K in total on Nov 2, 2026. Shares held after the trade: 13,823 (-12.6%).

Value
$284K
Shares
2,000
Price
$141.99
Role
Segment President
Holding change
-12.6%
Trade date
Nov 2, 2026
5:09 PM ET 8-K
Financial Results

Aptargroup Financial Results

AptarGroup reported third quarter 2026 results with sales increasing 6% to $1.02 billion and adjusted EPS of $1.52. Performance was driven by broad-based revenue growth across all three segments, particularly in Pharma's central nervous system and pulmonary therapies and double-digit core sales growth in Closures.

Term
Q3 2026

“We delivered broad-based revenue growth across all three segments. Pharma delivered impressive growth in central nervous system therapies, pulmonary, injectables and consumer healthcare, while maintaining profitability at the high end of our long-term target range.”

Gael Touya, Aptar President and CEO

“As I begin my tenure as CEO, our direction is clear: deepen our position with customers, accelerate innovation, execute with greater consistency and allocate capital thoughtfully. These priorities will guide how we drive profitable growth and create long-term value for Aptar and our shareholders.”

Gael Touya, Aptar President and CEO
5:09 PM ET 8-K
Other 8-K Filing

Aptargroup Other 8-K Filing

AptarGroup's Russian subsidiary, OOO Aptar Vladimir, has been placed under temporary external administration by a decree from the President of the Russian Federation. The company is assessing its options and legal rights regarding the subsidiary, which accounted for less than 0.6% of consolidated net sales and operating income as of late 2025. This event represents a loss of operational control over Russian assets due to geopolitical actions.

Counterparty
OOO Aptar Vladimir

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.